Patten & Patten’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-5,381
Closed -$340K 261
2020
Q3
$340K Buy
5,381
+100
+2% +$6.93K 0.03% 197
2020
Q2
$406K Buy
5,281
+1
+0% +$77 0.04% 187
2020
Q1
$395K Buy
+5,280
New +$365K 0.05% 174
2017
Q4
Sell
-2,590
Closed -$210K 244
2017
Q3
$210K Sell
2,590
-325
-11% -$24.9K 0.02% 239
2017
Q2
$206K Buy
+2,915
New +$194K 0.02% 240
2016
Q1
Sell
-2,598
Closed -$263K 212
2015
Q4
$263K Buy
+2,598
New +$270K 0.04% 196
2014
Q4
Sell
-7,050
Closed -$750K 211
2014
Q3
$750K Buy
+7,050
New +$690K 0.12% 128

Other funds holding GILD

Patten & Patten's GILD Position: Q4 2020 in Review

Patten & Patten sold out of Gilead Sciences (GILD) in Q4 2020, closing a stake of 5,381 shares — an estimated $340K sold.

Patten & Patten first reported a position in GILD in Q3 2014 and held it in 7 quarters. The position peaked at $750K in Q3 2014. 1,563 funds tracked by Wall St. Rank hold GILD as of Q4 2020.

  • Patten & Patten reported no remaining Gilead Sciences position as of Q4 2020 after selling out during the quarter.
  • Patten & Patten sold 5,381 Gilead Sciences shares in Q4 2020, an estimated $340K.
  • Patten & Patten first reported a position in Gilead Sciences in Q3 2014 and held it in 7 quarters.
  • Patten & Patten's Gilead Sciences position peaked at $750K in Q3 2014.
  • 1,563 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2020.

Based on Patten & Patten's 13F filing for Q4 2020, filed 19 Jan 2021.